|
OTUD7B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.666000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.390100E-02 |
| Normal-vs-Stage2 |
2.590400E-02 |
| Normal-vs-Stage3 |
4.523600E-02 |
| Normal-vs-Stage4 |
1.459240E-01 |
| Stage1-vs-Stage2 |
2.689200E-01 |
| Stage1-vs-Stage3 |
5.883200E-01 |
| Stage1-vs-Stage4 |
9.064800E-01 |
| Stage2-vs-Stage3 |
4.884000E-01 |
| Stage2-vs-Stage4 |
3.067400E-01 |
| Stage3-vs-Stage4 |
6.083800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.224000E-02 |
| Normal-vs-AfricanAmerican |
5.532200E-01 |
| Normal-vs-Asian |
8.744400E-02 |
| Caucasian-vs-AfricanAmerican |
1.281780E-02 |
| Caucasian-vs-Asian |
8.661200E-01 |
| AfricanAmerican-vs-Asian |
2.899500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.173700E-02 |
| Normal-vs-Female |
7.133900E-02 |
| Male-vs-Female |
2.479600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.066010E-01 |
| Normal-vs-Age(41-60Yrs) |
6.350500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.363500E-02 |
| Normal-vs-Age(81-100Yrs) |
6.600100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.922400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.577200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.296900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.129400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.058490E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.140000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.762100E-02 |
| Classical-VS-Follicular |
3.7116000051185E-08 |
| Classical-VS-Other |
2.247200E-01 |
| Classical-VS-Normal |
3.618200E-01 |
| Tall-VS-Follicular |
5.548400E-02 |
| Tall-VS-Other |
6.404400E-01 |
| Tall-VS-Normal |
2.995900E-02 |
| Follicular-VS-Other |
5.391600E-01 |
| Follicular-VS-Normal |
1.167400E-04 |
| Other-VS-Normal |
2.016800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.844100E-03 |
| Normal-vs-N1 |
2.179400E-01 |
| N0-vs-N1 |
1.327970E-01 |
|
|
